LDS/Medical Tests/IKBKAP (Inhibitor of Kappa Light Polypeptide Gene Enhancer in B-cells, Kinase Complex-associated Protein) Gene Mutation Analysis

IKBKAP (Inhibitor of Kappa Light Polypeptide Gene Enhancer in B-cells, Kinase Complex-associated Protein) Gene Mutation Analysis

The IKBKAP gene is located on the long arm of chromosome 9 at position 9q31.3 that encodes the scaffolding protein IKAP. IKAP is involved in pro-inflammatory cytokine signal transduction. It can bind NF-kB -inducing kinase and I-κ-B kinases and assemble to form an active kinase complex. IKAP is Elongator protein 1(ELP1), which is a member of the Elongator complex. ELP1 has a role in RNA polymerase II-mediated transcription elongation in the nucleus. In the cytoplasm, it is involved in multiple functions such as cell migration and adhesion, intracellular trafficking and cytoplasmic kinase signaling. Mutation in the IKBKAP (ELP1) gene is known to be associated with Familial dysautonomia.

Familial dysautonomia (FD) or Riley-Day syndrome is an autosomal recessive neurodegenerative disease which affects sensory and autonomic neurons. This disease is caused by a point mutation in the I-κ-B kinase complex which leads to a splicing error that reduces the amount of IKBKAP or IKAP protein. T to C transition at base pair 6 of IKBKAP intron [IVS20(+6)TC] and Arginine to proline substitution of amino acid residue 696 of IKAP [R696P] are the major mutation in >99% cases.

FD is exclusively limited to the Ashkenazi Jewish population. The carrier frequency in this population ranges from 1 in 27 to 1 in 32. FD is one of the members of neurodevelopmental disorders called ‘hereditary sensory and autonomic neuropathies’ (HSAN). The genetic defect disrupts prenatal neuronal development in all cases, but phenotypic expression varies. In the sensory nervous system, non-myelinated small fiber neurons are mostly affected. In the autonomic nervous system, decreased neuronal numbers are seen. The neurological symptoms seen are decreased deep tendon reflexes, decreased pain and temperature perception and ataxia. Postural hypotension, blotching, sweating and scoliosis are seen in most patients. Other symptoms include decreased tears, optic atrophy, dysphagia, gastroesophageal reflux and vomiting.

  • Diagnostic confirmation of familial dysautonomia in the Ashkenazi Jewish population
  • Prenatal and carrier screening in the Ashkenazi Jewish population

Most common mutation associated with familial dysautonomia:

  • T to C transition at base pair 6 of IKBKAP intron is the major mutation in >99% cases [IVS20(+6)TC].
  • Arginine to proline substitution of amino acid residue 696 of IKAP [R696P]

Negative for mutation analyzed (no pathogenic variant detected)

Polymerase chain reaction (PCR), conventional sequencing, Next Generation Sequencing.

Whole blood (EDTA), Amniotic fluid in prenatal, Chorionic villi.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
Ashkenazi Jewish Panel.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login